ReviewDer Pathologe2015
[Tumors of dendritic and other accessory cells of lymph nodes].
Review in Der Pathologe, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
- [Differential diagnosis of reactive cytopenias].Pathologie (Heidelberg, Germany) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Besides the obviously much more common lymphomas, neoplasms of dendritic and other so-called accessory cells can also primarily originate in lymph nodes. These include histiocytic sarcomas, follicular dendritic cell sarcomas, interdigitating dendritic cell sarcomas, fibroblastic reticulum cell tumors/cytokeratin-positive interstitial cell neoplasms and neoplasms of indeterminate dendritic cells. A feature common to all of these tumors is the very difficult differential diagnosis, not least because of their rarity; however, a careful analysis will allow discrimination from other sarcomas, sarcomatoid carcinomas, lymphomas and melanomas and lead to the correct classification of the respective lesions. From the pathogenetic view point it is interesting that there is an increased association of these tumors with lymphomas and leukemias. Moreover, many cases demonstrate shared clonal antigen receptor rearrangements and/or recurrent genetic aberrations in both histologically different tumor components. This suggests a common precursor cell or at least a common derivation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.